Consultant Paediatric Gastroenterologist and Clinical Director for Cambridge Children’s Hospital Project
Biography: Rob completed his specialist training at the Royal Free Hospital in London and Boston Children’s Hospital, US. This included 2 years as CICRA Research Fellow in paediatric IBD. He was appointed at Addenbrookes Hospital, Cambridge in 2008 to establish a regional specialty service for Paediatric Gastroenterology, Hepatology & Nutrition. As Clinical Lead for the service, Rob has supported the expansion of the clinical department and the development of the active integrated translational research program led by Matt Zilbauer. Since 2012, Rob divides his week equally between clinical care, predominantly of children with IBD, and management responsibilities. He completed 7 years as Divisional Director for Women & Children’s Services and now leads efforts to build a regional specialist hospital for children - Cambridge Children’s - on the biomedical campus.
Research & Service Development: Rob contributes actively to the ongoing translational research program and continues to take part in clinical trial activity for children with IBD. Other priorities include promoting patient engagement to improve and develop services offered to children and families.
Cambridge Children’s Hospital Project
Key publications
APOBEC mutagenesis is a common process in normal human small intestine.
Wang Y, Robinson PS, Coorens THH, Moore L, Lee-Six H, Noorani A, Sanders MA, Jung H, Katainen R, Heuschkel R, Brunton-Sim R, Weston R, Read D, Nobbs B, Fitzgerald RC, Saeb-Parsy K, Martincorena I, Campbell PJ, Rushbrook S, Zilbauer M, Buczacki SJA, Stratton MR
Nat Genet. 2023 Feb;55(2):246-254.
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease.
Serra EG, Schwerd T, Moutsianas L, Cavounidis A, Fachal L, Pandey S, Kammermeier J, Croft NM, Posovszky C, Rodrigues A, Russell RK, Barakat F, Auth MKH, Heuschkel R, Zilbauer M, Fyderek K, Braegger C, Travis SP, Satsangi J, Parkes M, Thapar N, Ferry H, Matte JC, Gilmour KC, Wedrychowicz A, Sullivan P, Moore C, Sambrook J, Ouwehand W, Roberts D, Danesh J, Baeumler TA, Fulga TA, Carrami EM, Ahmed A, Wilson R, Barrett JC, Elkadri A, Griffiths AM; COLORS in IBD group investigators; Oxford IBD cohort study investigators; INTERVAL Study; Swiss IBD cohort investigators; UK IBD Genetics Consortium; NIDDK IBD Genetics Consortium; Snapper SB, Shah N, Muise AM, Wilson DC, Uhlig HH, Anderson CA.
Nat Commun. 2020 Feb 21;11(1):995.
ESPGHAN position paper on management of percutaneous endoscopic gastrostomy in children and adolescents. Heuschkel RB, Gottrand F, Devarajan K, Poole H, Callan J, Dias JA, Karkelis S, Papadopoulou A, Husby S, Ruemmele F, Schäppi MG, Wilschanski M, Lionetti P, Orel R, Tovar J, Thapar N, Vandenplas Y; European Society for Pediatric Gastroenterology, Hepatology, and Nutrition
J Pediatr Gastroenterol Nutr. 2015 Jan;60(1):131-41.
Management guidelines of eosinophilic esophagitis in childhood.
Papadopoulou A, Koletzko S, Heuschkel R, Dias JA, Allen KJ, Murch SH, Chong S, Gottrand F, Husby S, Lionetti P, Mearin ML, Ruemmele FM, Schäppi MG, Staiano A, Wilschanski M, Vandenplas Y; ESPGHAN Eosinophilic Esophagitis Working Group and the Gastroenterology Committee.
J Pediatr Gastroenterol Nutr. 2014 Jan;58(1):107-18.
